FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to resuscitation, therapy, and can be used to determine an unfavorable immediate prognosis in the patients with pneumonia in A/H1N1 influenza by the nature of serum fermentemia. Patient with pneumonia in influenza A/H1N1 is diagnosed with an oxygenation index PaO2/FiO2 and an assessment of the clinical-laboratory criteria of sepsis in accordance with The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Laboratory levels of AST, ALT, LDH and CPK enzymes in blood serum are assessed with subsequent evaluation of the nearest disease prediction by fermentemia level. If the oxygenation index is within range of 300 to 200 mm Hg inclusive and the patient has no signs of sepsis, the fermentemia level does not affect the nearest prediction. If the patient's oxygenation index is less than 200 mm Hg with no signs of sepsis, the unfavorable outcome in assessing the nearest prognosis develops when the fermentemia increases from the reference level: LDH in 2.48 times and more, CPK in 3.36 times and more, AST in 2.35 times and more. If the patient's oxygenation index is less than 200 mm Hg and signs of sepsis are detected, the unfavorable immediate prognosis develops at fermentemia level AST in 2.65 times and more, ALT 2.3 times and more from the reference level.
EFFECT: method provides determining the unfavorable proximal prognosis in the patients with pneumonia in A/H1N1 influenza by the nature of serum fermentemia by conducting a patient with pneumonia in influenza A/H1N1 determining an oxygenation index and assessing the clinical-laboratory criteria of sepsis in accordance with current recommendations and laboratory assessment of blood serum AST, AST, LDH and CPK level.
1 cl, 7 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ASSESSING NEAREST DISEASE PROGNOSIS AND PROTEIN-ENERGY DEFICIENCY CORRECTION IN PATIENTS WITH INFLAMMATORY SYNDROME OF BACTERIAL GENESIS | 2019 |
|
RU2720824C1 |
METHOD OF DIAGNOSTICS AND PREDICTION OF SEPSIS OUTCOME | 2014 |
|
RU2568870C2 |
METHOD FOR PREDICTING ABDOMINAL SEPSIS SEVERITY DEGREE | 2004 |
|
RU2259159C1 |
METHOD OF REHABILITATION, COMBINING HYPO- AND HYPERBARIC OXYGENATION, FOR PATIENTS SUFFERING NEW CORONAVIRUS INFECTION | 2023 |
|
RU2821549C1 |
METHOD FOR PROPHYLAXIS OF CARDIAL COMPLICATIONS IN TOTAL HYPERTHERMIA WITH POLYCHEMOTHERAPY IN PATIENTS WITH ADVANCED CANCER FORMS | 2003 |
|
RU2233658C1 |
METHOD FOR PREDICTING RISK OF DEATH IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN COMBINATION WITH COVID-19 | 2021 |
|
RU2764954C1 |
METHOD FOR PREDICTING LETHAL OUTCOME IN PATIENTS WITH MULTIPLE ORGAN DYSFUNCTION | 2017 |
|
RU2670198C1 |
METHOD FOR MODELING SEVERE ACUTE RESPIRATORY SYNDROME IN EXPERIMENTAL ANIMALS | 2004 |
|
RU2280288C2 |
METHOD FOR PREDICTION OF THE CRIMEAN-CONGO HEMORRHAGIC FEVER OUTCOME | 2019 |
|
RU2706603C1 |
METHOD FOR PREDICTION OF OUTCOME OF VIRAL PNEUMONIA IN COVID-19 | 2021 |
|
RU2763764C1 |
Authors
Dates
2020-08-03—Published
2020-02-10—Filed